Clinical Trial Update: Revefenacin in Acute Respiratory Insufficiency in COPD [Phase 2]

View source ↗

Summary

A Phase 2 trial of revefenacin for COPD with acute respiratory insufficiency has completed, with an update on the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Respiratory Failure

Drugs mentioned

• Yupelri (revefenacin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: COPD, Acute Respiratory Failure | Phase 2 | Status: COMPLETED